risperidone has been researched along with fluvoxamine in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (14.04) | 18.2507 |
| 2000's | 33 (57.89) | 29.6817 |
| 2010's | 16 (28.07) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Honer, WG; Kopala, L | 1 |
| Epperson, CN; Fleischmann, RL; Leckman, JF; McDougle, CJ; Price, LH; Wasylink, S | 1 |
| Berigan, TR; Harazin, JS | 1 |
| Taylor, D | 1 |
| Kushnir, M; Silver, H | 1 |
| Day, C; Dillman, B; Gardner, D; Kopala, LC | 1 |
| Epperson, CN; Fasula, D; McDougle, CJ; Price, LH; Wasylink, S | 1 |
| Alfaro, CL; Lenane, M; Nicolson, R; Rapoport, JL | 1 |
| Lamberti, JS; Seger, A | 1 |
| Gabriel, A | 1 |
| Beddingfield, JJ; Mack, JE; Reeves, RR | 1 |
| Dwivedi, S; Heidenreich, J; Pavuluri, M; Wright, T | 1 |
| Ashby, CR; Hirose, S | 1 |
| Morinobu, S; Ohkawa, M; Tanaka, K; Yamashita, H; Yamawaki, S | 1 |
| Higuchi, H; Shimizu, T; Sugita, T; Takahashi, H | 1 |
| Ohmori, T; Sumitani, S | 1 |
| Cottingham, EM; McConville, BJ; Pathak, S | 1 |
| Alshari, MG; Bhatara, A; Bhatara, V; McMillin, JM; Warhol, P | 1 |
| Matsumiya, T; Miyamoto, J; Nawa, H; Ohzeki, M; Takeda, H; Tsuji, M | 1 |
| Bassi, T; Bellodi, L; Cavedini, P; Zorzi, C | 1 |
| Bellodi, L; Erzegovesi, S; Guglielmo, E; Siliprandi, F | 1 |
| Machida, N; Semba, J; Shiotsuka, S | 1 |
| Dinca, O; Paul, M; Spencer, NJ | 1 |
| Ancione, M; D'Arrigo, C; Migliardi, G; Morgante, L; Muscatello, MR; Santoro, V; Spina, E | 1 |
| Goldman, S | 1 |
| Kaneko, S; Nakamura, J; Shinkai, K; Yoshimura, R | 1 |
| Ago, Y; Baba, A; Matsuda, T; Nakamura, S; Sato, M | 1 |
| Harada, M; Kubo, H; Ohmori, T; Sumitani, S | 1 |
| Krystal, A; Lim, L | 1 |
| George, E; Haque, S; Soliman, S | 1 |
| Barton, R | 1 |
| Endo, T; Miyake, N; Miyamoto, S; Ogino, S; Yamaguchi, N | 1 |
| Weber, K | 1 |
| Karakatsanis, NA; Karapoulios, E; Konstantakopoulos, G; Kouzoupis, AV; Masdrakis, VG; Oulis, P; Soldatos, CR | 1 |
| Bagati, D; Goyal, N; Praharaj, SK; Sarkar, S; Sinha, P; Sinha, VK | 1 |
| Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ | 1 |
| Chetty, M; d'Esposito, F; Dore, G; Edwards, RJ; Glen, J; Murray, M; Ramzan, I; Stankovic, Z; Zhang, WV | 1 |
| Aukst-Margetić, B; Grgić, N; Kusmić, E; Marsanić, VB | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Nakamura, J; Yoshimura, R | 1 |
| Praharaj, SK; Pratheesh, PJ; Srivastava, A | 1 |
| Kurita, M; Nishino, S; Numata, Y; Okubo, Y; Sato, T; Takeyoshi, K; Tateno, A; Teranishi, M | 1 |
| Ago, Y; Hasebe, S; Hashimoto, H; Matsuda, T; Nishiyama, S; Oka, S; Takuma, K | 1 |
| Dwivedi, S; Kar, SK | 1 |
| Haji Seyed Javadi, A; Khanshir, ZF; Shafikhani, AA; Zamir, SM | 1 |
7 review(s) available for risperidone and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Clozapine; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluvoxamine; Haloperidol; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome | 1994 |
Pharmacokinetic interactions involving clozapine.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antipsychotic Agents; Caffeine; Cimetidine; Clozapine; Drug Interactions; Erythromycin; Fluvoxamine; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors | 1997 |
[The treatment of OCD].
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Drug Therapy, Combination; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors | 2003 |
Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.
Topics: Adolescent; Antipsychotic Agents; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Cross-Over Studies; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Randomized Controlled Trials as Topic; Reproducibility of Results; Risperidone; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome | 2005 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
Asperger's syndrome: from hiding to thriving.
Topics: Adaptation, Psychological; Asperger Syndrome; Benzodiazepines; Causality; Central Nervous System Depressants; Child; Child Behavior; Diagnosis, Differential; Early Diagnosis; Fluvoxamine; Humans; Interpersonal Relations; Melatonin; Nurse Practitioners; Nursing Assessment; Olanzapine; Prevalence; Primary Health Care; Prognosis; Psychological Tests; Psychology, Child; Risperidone; Serotonin Agents; Social Behavior; United States | 2008 |
8 trial(s) available for risperidone and fluvoxamine
| Article | Year |
|---|---|
Risperidone addition in serotonin reuptake inhibitor-resistant trichotillomania: three cases.
Topics: Adult; Chronic Disease; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Trichotillomania | 1999 |
An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Antipsychotic Agents; Depressive Disorder; Drug Administration Schedule; Female; Fluvoxamine; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial.
Topics: Antipsychotic Agents; Chronic Disease; Drug Interactions; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
The advantages of choosing antiobsessive therapy according to decision-making functioning.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Decision Making; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Risperidone; Single-Blind Method | 2004 |
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Time Factors; Treatment Outcome | 2005 |
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2009 |
Efficacy and tolerability of risperidone, yokukansan, and fluvoxamine for the treatment of behavioral and psychological symptoms of dementia: a blinded, randomized trial.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Basal Ganglia Diseases; Central Nervous System Agents; Chi-Square Distribution; Dementia; Drugs, Chinese Herbal; Female; Fluvoxamine; Humans; Japan; Male; Multivariate Analysis; Psychiatric Status Rating Scales; Risperidone; Time Factors; Treatment Outcome | 2013 |
Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Young Adult | 2018 |
42 other study(ies) available for risperidone and fluvoxamine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Fluvoxamine; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin | 1994 |
Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
Topics: Adult; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Treatment Outcome | 1995 |
Response to risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.
Topics: Drug Therapy, Combination; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Risperidone; Treatment Outcome | 1996 |
Treatment of aggression in schizophrenia.
Topics: Adult; Aggression; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Risperidone; Schizophrenia; Schizophrenic Psychology | 1998 |
A case of risperidone overdose in early schizophrenia: a review of potential complications.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Interactions; Drug Overdose; Electrocardiography; Fluvoxamine; Heart Block; Humans; Hypotension; Male; Risperidone; Schizophrenia; Suicide, Attempted | 1998 |
Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Risperidone; Schizophrenia | 2000 |
Priapism associated with polypharmacy.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Polypharmacy; Priapism; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Trichotillomania | 2001 |
Neurotoxic syndrome associated with risperidone and fluvoxamine.
Topics: Adult; Antipsychotic Agents; Drug Interactions; Female; Fluvoxamine; Humans; Neuroleptic Malignant Syndrome; Neurotoxicity Syndromes; Risperidone; Selective Serotonin Reuptake Inhibitors | 2002 |
Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.
Topics: Adolescent; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2002 |
Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.
Topics: Adult; Comorbidity; Drug Therapy, Combination; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sleep Disorders, Circadian Rhythm; Treatment Outcome | 2002 |
The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent.
Topics: Adolescent; Antipsychotic Agents; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan | 2003 |
Coexistent hypothyroidism, psychosis, and severe obsessions in an adolescent: a 10-year follow-up.
Topics: Adolescent; Aggression; Antipsychotic Agents; Fluvoxamine; Hospitalization; Humans; Hypothyroidism; Male; Obsessive Behavior; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors; Suicide; Thyrotropin; Thyroxine | 2004 |
Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm.
Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Cyclopropanes; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Milnacipran; Risperidone; Serotonin Antagonists; Stress, Physiological | 2004 |
[Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI].
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Fluvoxamine; Haloperidol; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Personality Disorders; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2005 |
Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluvoxamine; Humans; Male; Middle Aged; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2005 |
Possible antipsychotic effect of fluvoxamine.
Topics: Antipsychotic Agents; Citalopram; Delayed-Action Preparations; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Injections, Intramuscular; Middle Aged; Psychotic Disorders; Risperidone | 2005 |
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2006 |
Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Depression; Drug Interactions; Drug Therapy, Combination; Fluvoxamine; Loxapine; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Sulpiride; Time Factors | 2006 |
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
Psychotic disorder in a patient with central and extrapontine myelinolysis.
Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Baclofen; Female; Fluvoxamine; GABA Agonists; Humans; Magnetic Resonance Imaging; Middle Aged; Movement Disorders; Myelinolysis, Central Pontine; Psychotic Disorders; Quadriplegia; Risperidone; Trihexyphenidyl | 2007 |
Stalking and Huntington's disease: a neurobiological link?
Topics: Aggression; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Female; Fluvoxamine; Forensic Psychiatry; Humans; Huntington Disease; Middle Aged; Obsessive Behavior; Risperidone | 2007 |
Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Fluvoxamine; Humans; Male; Meige Syndrome; Olanzapine; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 2007 |
Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.
Topics: Adult; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Fluvoxamine; GABA Agonists; Humans; Nipecotic Acids; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Tiagabine | 2009 |
Musical obsession or pseudohallucination: electrophysiological standpoint.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Drug Therapy, Combination; Electroencephalography; Electrophysiology; Fluvoxamine; Fourier Analysis; Hallucinations; Humans; Male; Music; Obsessive-Compulsive Disorder; Risperidone; Young Adult | 2009 |
In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation.
Topics: Adult; Antipsychotic Agents; Biotransformation; Chromatography, High Pressure Liquid; Clozapine; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Interactions; Female; Fluvoxamine; Humans; Ketoconazole; Male; Microsomes, Liver; Middle Aged; Risperidone; Schizophrenia; Young Adult | 2009 |
Misdiagnosis and exacerbation of unusual obsessive-compulsive disorder presentation with risperidone and clozapine in an adolescent girl - A case report.
Topics: Adolescent; Antipsychotic Agents; Clozapine; Diagnostic Errors; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Psychotic Disorders; Risperidone | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
[Effects of smoking and caffeine on pharmacological treatment for patients with schizophrenia and depression].
Topics: Caffeine; Depression; Drug Interactions; Fluvoxamine; Humans; Risperidone; Schizophrenia; Smoking | 2011 |
Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.
Topics: Drug Therapy, Combination; Fluvoxamine; Galactorrhea; Gynecomastia; Humans; Male; Obsessive-Compulsive Disorder; Prolactin; Risperidone; Selective Serotonin Reuptake Inhibitors; Young Adult | 2011 |
Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice.
Topics: Animals; Animals, Outbred Strains; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Desipramine; Duloxetine Hydrochloride; Fluvoxamine; Hydroxycorticosteroids; Idazoxan; Indoles; Male; Mice; Motor Activity; Neuropsychological Tests; Oxazines; Paroxetine; Piperazines; Psychotropic Drugs; Pyridines; Risperidone; Ritanserin; Social Behavior; Social Isolation; Sulfonamides; Venlafaxine Hydrochloride | 2015 |
Alcohol binge drinking in OCD: A compulsive ritualistic behaviour to counter magical thinking.
Topics: Adult; Antipsychotic Agents; Binge Drinking; Ceremonial Behavior; Clonazepam; Cognitive Behavioral Therapy; Compulsive Behavior; Fluvoxamine; GABA Modulators; Humans; Magic; Male; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors | 2017 |